Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

AI Is Accelerating Drug Development; But Data Risks Could Break It

BioSpace’s NextGen 2026 biotech leaders highlighted at a recent industry discussion how artificial intelligence is rapidly reshaping drug development while exposing a critical weakness in pharmaceutical innovation: data quality. Executives from emerging biotech companies emphasized that while AI accelerates discovery
  • News
AI Is Accelerating Drug Development; But Data Risks Could Break It

Aragen completes FDA Fast Track mAb scale-up; what enabled this 9-month turnaround

Aragen has completed technology transfer and initiated first commercial-scale GMP manufacturing runs for Renaissance Pharma’s lead monoclonal antibody Daretabart at its Bengaluru facility in India. The company originally developed the cell line and early process at its Morgan Hill site
  • News
Aragen completes FDA Fast Track mAb scale-up; what enabled this 9-month turnaround

Why Inspection Readiness Is Becoming Harder; Digital GMP Raises New Risks

In a recent interview with Christopher Cole of Pharmaceutical Technology, Henrik Johanning from Epista Life Science discussed how pharmaceutical manufacturing and regulatory systems in Europe are shifting from 2025 into 2026. He explained that quality risk management, digital GMP, and
  • News
Why Inspection Readiness Is Becoming Harder; Digital GMP Raises New Risks

FDA Leadership Shakeup Raises Alarm; DTC Drug Ads Face Sudden Enforcement Shift

In September 2025, President Donald Trump called for stricter enforcement of existing rules on direct-to-consumer (DTC) prescription drug advertising by the U.S. Food and Drug Administration (FDA). Around the same period, HHS Secretary Robert F. Kennedy Jr. also criticized pharmaceutical
  • News
FDA Leadership Shakeup Raises Alarm; DTC Drug Ads Face Sudden Enforcement Shift

CSV Documentation in 2026: GMP Compliance, Data Integrity, and Inspection Readiness

This article explains how CSV Documentation supports GMP compliance in computerized systems, focusing on validation traceability, IQ OQ PQ documentation, and data integrity requirements aligned with FDA 21 CFR Part 11 and EU Annex 11 expectations.
  • Blog, Validation and Qualification
Pharmaceutical validation documentation workflow for Computer System Validation (CSV) in GMP computerized systems, highlighting validation traceability matrix, IQ OQ PQ documentation, and compliance with GAMP 5 validation and data integrity standards.

AI in Clinical Trials Faces Trust Crisis; Regulatory Uncertainty Grows

A recent survey by the Pistoia Alliance at the Clinical Trials Technology Congress (CTTC) in London shows that trust issues and regulatory uncertainty continue to slow artificial intelligence adoption in clinical trials. Although AI already delivers early value in clinical
  • News
AI in Clinical Trials Faces Trust Crisis; Regulatory Uncertainty Grows

FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical

The FDA is urging pharmaceutical companies to re-examine decades of clinical and real-world data using AI and advanced analytics to identify new uses for existing drugs. Published on May 29, 2026, this initiative highlights how legacy datasets may still hold
  • News
FDA Quietly Rewrites Drug Repurposing Rules; Pharma Data Validation Suddenly Becomes Critical

Sterile Area Maintenance in 2026: Inspection Readiness

Sterile Area Maintenance in 2026 examines how cleanroom control failures impact GMP inspection outcomes. This article explains key contamination risks, regulatory expectations, and maintenance practices that influence sterile manufacturing compliance and inspection readiness in pharmaceutical environments.
  • Blog, Quality Management System
Process flow diagram showing how cleanroom maintenance failures escalate into contamination risk during sterile manufacturing GMP inspections